American Journal of Clinical Dermatology

, Volume 4, Issue 3, pp 165–175 | Cite as

Staphylococcal Scalded Skin Syndrome

Diagnosis and Management
Therapy in Practice

Abstract

Staphylococcal scalded skin syndrome (SSSS) is a common disorder that is usually seen in infants and children and rarely seen in adults. SSSS usually presents with a prodrome of sore throat or conjunctivitis. Extremely tender flaccid bullae, which are Nikolsky sign-positive, develop within 48 hours and commonly affect the flexures; occasionally, large areas of the skin may be involved. The bullae enlarge and rupture easily to reveal a moist erythematous base, which gives rise to the scalded appearance.

SSSS in adults is a rare disorder, though there are now over 50 documented cases. Usually SSSS occurs in predisposed individuals, but not all adults have an underlying illness. Whereas mortality in childhood SSSS is approximately 4%, the mortality rate in adults is reported to be greater than 60%.

SSSS is caused by an infection with a particular strain of Staphylococcus aureus, which leads to blistering of the upper layer of the skin, by the release of a circulating exotoxin. It has recently been demonstrated that the exfoliative exotoxin responsible for SSSS leads to the cleavage of desmoglein 1 complex, an important desmosomal protein. The same toxins that are responsible for causing SSSS also cause bullous impetigo. There appears to be a relationship between the disease extent, the amount of toxin produced and whether the toxin is released locally or systemically. As a result there is likely to be a spectrum of disease and there are likely to be a number of milder cases of adult SSSS that go undiagnosed.

Social improvements and hygiene have led to a dramatic fall in the number of cases of SSSS. Treatment is usually straightforward, when there is no coexistent morbidity and the presentation is mild, but can be demanding if the patient is particularly ill. SSSS is still associated with mortality, particularly when it occurs in adults.

References

  1. 1.
    Ritter von Rittershain G. Die exfoliativa dermatitis jüngerer Säulinge. Centralz Kinderheilk 1878; 2: 3–23Google Scholar
  2. 2.
    Lyell A. Toxic epidermal necrolysis: an eruption resembling scalding of the skin. Br J Dermatol 1956; 68: 355–361PubMedCrossRefGoogle Scholar
  3. 3.
    Lyell A, Dick HM, Alexander JO. Outbreak of toxic epidermal necrolysis associated with staphylococci. Lancet 1969; I: 787–789CrossRefGoogle Scholar
  4. 4.
    Lyell A. A review of toxic epidermal necrolysis in Britain. Br J Dermatol 1967; 79: 662–671PubMedCrossRefGoogle Scholar
  5. 5.
    Jefferson J. Lyell’s toxic epidermal necrolysis: a staphylococcal aetiology? BMJ 1967; 555: 802–804CrossRefGoogle Scholar
  6. 6.
    Tyson RG, Ushinski SC, Kisilevsky R. Toxic epidermal necrolysis (the scalded skin syndrome): its association in two cases with pathogenic staphylococci and its similarity in infancy to Ritter’s disease. Am J Dis Child 1966; 111: 386–392PubMedGoogle Scholar
  7. 7.
    Messaritakis J. Toxic epidermal necrolysis in children: description of 4 cases. Ann Paediatr 1966; 207 (4): 236–246PubMedGoogle Scholar
  8. 8.
    Melish ME, Glasgow LA. The staphylococcal scalded-skin syndrome. N Engl J Med 1970; 282: 1114–1119PubMedCrossRefGoogle Scholar
  9. 9.
    Kapral FA, Miller MM. Product of Staphylococcus aureus responsible for the scalded skin syndrome. Infect Immun 1971; 4: 541–545PubMedGoogle Scholar
  10. 10.
    Melish ME, Glasgow LA, Turner MD. Staphylococcal scalded skin syndrome: isolation and partial characterisation of the exfoliative toxin. J Infect Dis 1972; 125: 129–140PubMedCrossRefGoogle Scholar
  11. 11.
    Elias PM, Fritsch P, Mittermayer H, et al. Experimental staphylococcal toxic epidermal necrolysis (TEN) in adult humans and mice. J Lab Clin Med 1974; 84: 414–424PubMedGoogle Scholar
  12. 12.
    Lyell A. The staphylococcal scalded skin syndrome a historical perspective: emergence of dermopathic strains of Staphylococcal aureus and the discovery of the epidermolytic toxin. J Am Acad Dermatol 1983; 9: 285–294PubMedCrossRefGoogle Scholar
  13. 13.
    Levine G, Norden CW. Staphylococcal scalded skin syndrome in an adult. N Engl J Med 1972; 287: 1339–1340PubMedCrossRefGoogle Scholar
  14. 14.
    Patel GK, Varma S, Finlay AY. Staphylococcal scalded skin syndrome in healthy adults. Br J Dermatol 2000; 142 (6): 1253–1255PubMedCrossRefGoogle Scholar
  15. 15.
    Amagai M, Matsuyoshi N, Wang ZH, et al. Toxin in bullous impetigo and staphylococcal scalded skin syndrome targets desmoglein 1. Nature Med 2000; 6: 1275–1277PubMedCrossRefGoogle Scholar
  16. 16.
    Elias PM, Fritsch P, Epstein EV. Staphylococcal scalded skin syndrome: clinical features, pathogenesis, and recent microbiological and biochemical developments. Arch Dermatol 1977; 113: 207–219PubMedCrossRefGoogle Scholar
  17. 17.
    Elias PM, Levy SW. Bullous impetigo: occurrence of scalded skin syndrome in an adult. Arch Dermatol 1976; 112: 856–858PubMedCrossRefGoogle Scholar
  18. 18.
    Falk DK, King LE. Criteria for the diagnosis of Staphylococcal scalded skin syndrome in adults. Cutis 1983; 31: 431–434Google Scholar
  19. 19.
    Lowney ED, Baublis JV, Kreye GM, et al. The scalded skin syndrome in small children. Arch Dermatol 1967; 95: 359–369PubMedCrossRefGoogle Scholar
  20. 20.
    Moss C, Gupta E. The Nikolsky sign in staphylococcal scalded skin syndrome [letter]. Arch Dis Child 1998; 79: 290PubMedCrossRefGoogle Scholar
  21. 21.
    Shelley ED, Shelley WB, Talanin NY. Chronic staphylococcal scalded skin syndrome. Br J Dermatol 1998; 139: 319–324PubMedCrossRefGoogle Scholar
  22. 22.
    Reid LH, Weston WL, Humbert JR. Staphylococcal scalded skin syndrome: adult patient with deficient cell mediated immunity. Arch Dermatol 1976; 112: 1275–1279CrossRefGoogle Scholar
  23. 23.
    Fine JD, Harrist TJ, Radford MJ. Adult scalded skin syndrome fatally complicated by mixed gram-negative sepsis and cellulitis. Cutis 1981; 27: 162–167PubMedGoogle Scholar
  24. 24.
    Norden CW, Mendelow H. Staphylococcal scalded skin syndrome in adults [letter]. N Engl J Med 1974; 290: 577PubMedGoogle Scholar
  25. 25.
    Todd JK. Staphylococcal toxin syndromes. Annu Rev Med 1985; 36: 337–347PubMedCrossRefGoogle Scholar
  26. 26.
    Amon RB, Dimond RL. Toxic epidermal necrolysis: rapid differentiation between staphylococcal- and drug-induced disease. Arch Dermatol 1975; 111: 1433–1437PubMedCrossRefGoogle Scholar
  27. 27.
    Dimond RL, Wolff HH, Braun-Falco O. The staphylococcal scalded skin syndrome: an experimental histochemical and electron microscopy study. Br J Dermatol 1977; 96: 483–492PubMedCrossRefGoogle Scholar
  28. 28.
    Robinson ND, Hashimoto T, Amagai M, et al. The new pemphigus variants. J Am Acad Dermatol 1999; 40: 649–671PubMedCrossRefGoogle Scholar
  29. 29.
    Breathnach SM, McGibbon DH, Ives FE, et al. Carbamazepine (Tegretol) and toxic epidermal necrolysis: report of three cases with histopathological observations. Clin Exp Dermatol 1982; 7: 585–591PubMedCrossRefGoogle Scholar
  30. 30.
    Gillespie WA, Pope RC, Simpson K. Pemphigus neonatorum caused by Staphylococcal aureus type 71. BMJ 1957; 1: 1044–1046PubMedCrossRefGoogle Scholar
  31. 31.
    Willard D, Montell H, Piermont Y, et al. Exfoliatine dans les staphylococcies neonatales. Nouv Presse Med 1982; 11: 3769–3771PubMedGoogle Scholar
  32. 32.
    Parker MT. Some cultural characteristics of Staphylococcus aureus strains from superficial skin infections. J Hyg (Lond) 1958; 56: 238–253CrossRefGoogle Scholar
  33. 33.
    Arbuthnott JP, Kent K, Lyell A, et al. Toxic epidermal necrolysis produced by an extracellular product of Staphylococcus aureus. Br J Dermatol 1971; 85: 145–149PubMedCrossRefGoogle Scholar
  34. 34.
    Lina G, Gillet Y, Vadenesch F, et al. Toxin involvement in Staphylococcal scalded skin syndrome. Clin Infect Dis 1997; 25: 1369–1373PubMedCrossRefGoogle Scholar
  35. 35.
    Arbuthnott JP, Gemmel CG, Kent J, et al. Haemolysin and enzyme patterns of coagulase-positive staphylococci isolated from toxic epidermal necrolysis, Ritter’s disease and impetigo contagiosa. J Med Microbiol 1969; 2: 479–487PubMedCrossRefGoogle Scholar
  36. 36.
    Dancer SJ, Garratt R, Saldanha J, et al. The epidermolytic toxins are serine proteinases. FEBS Lett 1990; 268: 129–132PubMedCrossRefGoogle Scholar
  37. 37.
    Wiley BB, Allman S, Rogolsky M, et al. Staphylococcal scalded skin syndrome: potentiation by immunosuppression in mice; toxin-mediated exfoliation in a healthy adult. Infect Immun 1974; 9: 636–640PubMedGoogle Scholar
  38. 38.
    Rogolosky M, Wiley BB, Glasgow LA. Phage group II Staphylococcal strains with chromosomal and extra-chromosomal genes for exfoliative toxin production. Infect Immun 1976; 13: 44–52Google Scholar
  39. 39.
    Oono T, Kanzaki H, Yoshioka T, et al. Staphylococcal scalded skin syndrome in an adult: identification of exfoliative toxin A and B genes by polymerase chain reaction. Dermatology 1997; 195: 268–270PubMedCrossRefGoogle Scholar
  40. 40.
    Criber B, Piemont Y, Grosshans E. Staphylococcal scalded skin syndrome in adults. J Am Acad Dermatol 1994; 30: 319–324CrossRefGoogle Scholar
  41. 41.
    Kawabata A, Ichiyama S, Iinuma Y, et al. Exfoliative toxin detection using reverse passive latex agglutination: clinical and epidemiologic application. J Clin Microbiol 1997; 35: 1984–1987PubMedGoogle Scholar
  42. 42.
    Sarai Y, Nikahara H, Ishikawa T, et al. A bacteriological study on children with staphylococcal toxic epidermal necrolysis in Japan. Dermatologica 1977; 154: 161–167PubMedCrossRefGoogle Scholar
  43. 43.
    Murono K, Fujita K, Yoshika H. Microbiological characteristics of exfoliative toxin-producing Staphylococcus aureus. Paediatr Infect Dis J 1988; 7: 313–315CrossRefGoogle Scholar
  44. 44.
    De Azevedo JCS, Arbuthnott JP. Assays for epidermolytic toxin of Staphylococcus aureus. Methods Enzymol 1988; 165: 333–338CrossRefGoogle Scholar
  45. 45.
    Rifai S, Barbancon V, Prevost G, et al. Synthetic exfoliative toxin A and B DNA probes for detection of toxigenic Staphylococcus aureus strains. J Clin Microbiol 1989; 27: 504–506PubMedGoogle Scholar
  46. 46.
    Murono K, Fujita K, Yoskioka H. Detection of staphylococcal exfoliative toxin by slide latex agglutination. J Clin Microbiol 1988; 26: 271–274PubMedGoogle Scholar
  47. 47.
    Hoeger PH, Elsner P. Staphylococcal scalded skin syndrome: transmission of the exfoliatin-producing Staphylococcus aureus by asymptomatic carriers. Pediatr Infect Dis 1988; 7: 340–342CrossRefGoogle Scholar
  48. 48.
    Dave J, Reith S, Nash JQ, et al. A double outbreak of exfoliative toxin-producing strains of Staphylococcus aureus in a maternity unit. Epidemiol Infect 1994; 112: 103–114PubMedCrossRefGoogle Scholar
  49. 49.
    Curran JP, Al-Sahili FL. Neonatal staphylococcal scalded skin syndrome: massive outbreak due to an unusual phage type. Paediatrics 1980; 66: 285–290Google Scholar
  50. 50.
    Opal SM, Johnson-Winegar AD, Cross AS. Staphylococcal scalded skin syndrome in two immunocompetent adults caused by exfoliating B-producing Staphylococcus aureus. J Clin Microbiol 1988; 26: 1283–1286PubMedGoogle Scholar
  51. 51.
    Diem E, Konrad K, Graninger W. Staphylococcal scalded skin syndrome in an adult with fatal disseminated sepsis. Acta Derm Venereol (Stockh) 1982; 62: 295–299Google Scholar
  52. 52.
    Petzelbauer P, Konrad K, Wolff K. Staphylococcal scalded skin syndrome in 2 adults with acute kidney failure. Hautarzt 1989; 40: 90–93PubMedGoogle Scholar
  53. 53.
    Rothenberg R, Renna F, Drew T. Staphylococcal scalded skin syndrome in an adult. Arch Dermatol 1973; 108: 408–410PubMedCrossRefGoogle Scholar
  54. 54.
    Neefe LI, Tuazon CV, Cardella TA, et al. Staphylococcal scalded skin syndrome in adults: case report and review of the literature. Am J Med Sci 1979; 277: 99–110PubMedCrossRefGoogle Scholar
  55. 55.
    Borchers SL, Gomez EC, Isseroff RR. Generalized staphylococcal scalded skin syndrome in an anephric boy undergoing hemodialysis. Arch Dermatol 1984; 120: 912–918PubMedCrossRefGoogle Scholar
  56. 56.
    Donohue D, Robinson B, Goldberg NS. Staphylococcal scalded skin syndrome in a woman with chronic renal failure exposed to human immunodeficiency virus. Cutis 1991; 47: 317–318PubMedGoogle Scholar
  57. 57.
    Elsner P, Hartmann AA. Epidemiology of ETA- and ETB- producing staphylococci in dermatological patients [abstract]. Zentralbl Bakteriol Mikrobiol Hyg [A] 1988; 268: 534Google Scholar
  58. 58.
    Arbuthnott JP. Characterisation of the epidermolytic toxins of Staphylococcus aureus. In: Macdonald A, Smith G, editors. The Staphylococci: proceedings of the Alexander Ogston Centennial Conference. Aberdeen: Aberdeen University Press, 1981: 109–118Google Scholar
  59. 59.
    Acland KM, Darvay A, Griffin C, et al. Staphylococcal scalded skin syndrome in an adult associated with methicillin-resistant Staphylococcus aureus. Br J Dermatol 1999; 140: 518–520PubMedCrossRefGoogle Scholar
  60. 60.
    McLay ALC, Arbuthnott JP, Lyell A. Action of Staphylococcal epidermolytic toxin on mouse skin: an electron microscopy study. J Invest Dermatol 1975; 65: 423–428PubMedCrossRefGoogle Scholar
  61. 61.
    Sato H, Matsumori Y, Tanabe T, et al. A new type of staphylococcal exfoliative toxin from a Staphylococcus aureus strain isolated from a horse with phlegmon. Infect Immun 1994; 62: 3780–3785PubMedGoogle Scholar
  62. 62.
    Lillibridge CB, Melish ME, Glasgow LA. Site of action of exfoliative toxin in the staphylococcal scalded skin syndrome. Pediatrics 1972; 50: 728–738PubMedGoogle Scholar
  63. 63.
    Kapral FA, Miller NM. Product of Staphylococcal aureus responsible for the staphylococcal scalded skin syndrome. Infect Immun 1971; 4: 541–545PubMedGoogle Scholar
  64. 64.
    Arbuthnott JP, Kent J, Lyell A, et al. Studies of staphylococcal toxins in relation to toxic epidermal necrolysis: the scalded skin syndrome [supplement]. Br J Dermatol 1972; 86: s35–s39CrossRefGoogle Scholar
  65. 65.
    Wuepper KD, Dimond RL, Knutson DD. Studies of the mechanism of epidermal injury by Staphylococcal epidermolytic toxin. J Invest Dermatol 1975; 65: 191–200PubMedCrossRefGoogle Scholar
  66. 66.
    Melish ME, Chen FS, Sprouse S, et al. Epidermolytic toxin in staphylococcal infection: toxin levels and host response. Zentralbl Bakteriol Mikrobiol Hyg Suppl 1981; 10: 287–298Google Scholar
  67. 67.
    Bailey CJ, de Azavedo J, Arbuthnott JP. A comparative study of two serotypes of epidermolytic toxin from Staphylococcus aureus. Biochim Biophys Acta 1980; 624: 111–120PubMedCrossRefGoogle Scholar
  68. 68.
    Kondo I, Sakurai S, Sarai Y. New type of exfoliatin obtained from staphylococcal strains, belonging to phage groups other than group II, isolated from patients with impetigo and Ritter’s disease. Infect Immun 1974; 10: 851–861PubMedGoogle Scholar
  69. 69.
    Sakurai S, Suzuki H, Kondo I. DNA sequencing of the eta gene coding for Staphylococcal exfoliative toxin serotype A. J Gen Microbiol 1988; 134: 711–717PubMedGoogle Scholar
  70. 70.
    Lee CY, Schmidt JJ, Johnson-Winegar AD, et al. Sequence determination and comparison of exfoliative toxin A and B genes from Staphylococcal aureus. J Bacteriol 1987; 169: 3904–3909PubMedGoogle Scholar
  71. 71.
    O’Toole PW, Foster TJ. Nucleotide sequence of the epidermolytic toxin A gene of Staphylococcus aureus. J Bacteriol 1987; 169: 3910–3915PubMedGoogle Scholar
  72. 72.
    Sakuria S, Suzuki H, Kondo I. Cloning of the gene coding for Staphylococcal exfoliative toxin A and its expression in Escherichia coli. FEMS Microbiol Lett 1987; 42: 63–67CrossRefGoogle Scholar
  73. 73.
    Smith TP, John DA, Bailey CJ. The binding of epidermolytic toxin from staphylococcus aureus to mouse epidermal tissue. Histochem J 1987; 19: 135–149CrossRefGoogle Scholar
  74. 74.
    Gentihomme E, Faure M, Piemont Y, et al. Action of staphylococcal exfoliative toxins on epidermal cell cultures and organotypic skin. J Dermatol 1990; 17: 526–532Google Scholar
  75. 75.
    Vath GM, Earhart CA, Rago JV, et al. The structure of the superantigen exfoliative toxin A suggests a novel regulation as a serine protease. Biochemistry 1997; 36: 1559–1566PubMedCrossRefGoogle Scholar
  76. 76.
    Prevost G, Rifai S, Chaix ML, et al. Functional evidence that Ser-195 residue of Staphylococcal exfoliative toxin A is essential for biological activity. Infect Immun 1991; 59: 3337–3339PubMedGoogle Scholar
  77. 77.
    Redpath MB, Foster TJ, Bailey CJ. The role of serine protease active site in the mode of action of epidermolytic toxin of S. aureus. FEMS Microbiol Lett 1991; 81: 151–156CrossRefGoogle Scholar
  78. 78.
    Jaulhac B, Piemont Y, Prevost G. Staphylococcal exfoliative toxins induce proteolytic activity when combined with epidermis. In: Mollby R, Flock JI, Nord CE, et al., editors. Staphylococci and staphylococcal infections. New York: Gustav Fischer Verlag, 1994: 280–282Google Scholar
  79. 79.
    Barbosa JARG, Saldanaha JW, Garratt RC. Novel features of serine protease active sites and specificity pockets: sequence analysis and modelling studies of glutamate-specific endopeptidases and epidermolytic toxins. Protein Eng 1996; 9: 591–601PubMedCrossRefGoogle Scholar
  80. 80.
    Rago JV, Vath GM, Tripp TJ, et al. Staphylococcal exfoliative toxins cleave alphaand beta-melanocyte-stimulating hormones. Infect Immun 2000; 68: 2366–2368PubMedCrossRefGoogle Scholar
  81. 81.
    Mahoney MG, Wang Z, Rothenberger K, et al. Explanation for the clinical and microscopic localization of lesions in pemphigus foliaceous and vulgaris. J Clin Invest 1999; 103: 461–468PubMedCrossRefGoogle Scholar
  82. 82.
    Marrack P, Kappler J. The staphylococcal enterotoxins and their relatives. Science 1990; 346: 471–473Google Scholar
  83. 83.
    Khuong MA, Chosidow O, Solh NE, et al. Staphylococcal scalded skin syndrome in an adult: possible influence of non-steroidal anti-inflammatory drugs. Dermatology 1993; 186: 153–154PubMedCrossRefGoogle Scholar
  84. 84.
    Haas Baker D, Wuepper KD, Rasmussen JE. Staphylococcal scalded skin syndrome: detection of antibody to epidermolytic toxin by a primary binding assay. Clin Exp Dermatol 1978; 3: 17–24CrossRefGoogle Scholar
  85. 85.
    Wiley B, Glasgow L, Rogolsky M. Studies on staphylococcal scalded skin syndrome (SSSS): isolation and purification of toxin and development of a radioimmunobinding assay for antibodies to exfoliative toxin (ET). In: Jeljaszewicz J, editor. Staphylococci and staphylococcal diseases. Stuttgart: Gustav Fischer Verlag, 1976: 499–516Google Scholar
  86. 86.
    Beer B, Wilson B. Adult staphylococcal scalded skin syndrome. Int J Dermatol 1990; 29: 428–429CrossRefGoogle Scholar
  87. 87.
    Herzog JL, Sexton M. Desquamative rash in an immunocompromised adult. Arch Dermatol 1990; 26: 815–819CrossRefGoogle Scholar
  88. 88.
    Trentham DE, Silvermann HA, Townes AS. Cause of adult toxic epidermal necrolysis [letter]. N Engl J Med 1975; 292: 870PubMedGoogle Scholar
  89. 89.
    Saiag P, Caumes E, Roujeau JC, et al. Epidermolyse staphylococcique (syndrome de Lyell staphylococcique) de l’adult: 2 cas. Ann Dermatol Venereol 1988; 115: 1164–1166PubMedGoogle Scholar
  90. 90.
    Fritsch P, Elias P, Varga J. The fate of Staphylococcal exfoliatin in newborn and adult mice. Br J Dermatol 1976; 95: 275–284PubMedCrossRefGoogle Scholar
  91. 91.
    Kirmani N, Tauzon CU, Murray HW, et al. Staphylococcus aureus carriage rate of patients receiving long term haemodialysis. Arch Intern Med 1978; 138: 467–475CrossRefGoogle Scholar
  92. 92.
    Rothenburg R, Renna FS, Drew TM, et al. Staphylococcal scalded skin syndrome in an adult. Arch Dermatol 1973; 108: 408–410CrossRefGoogle Scholar
  93. 93.
    Epstein Jr EH, Flynn P, Davis RS. Adult toxic epidermal necrolysis and fatal staphylococcal septicaemia. JAMA 1974; 229: 425–427PubMedCrossRefGoogle Scholar
  94. 94.
    O’Keefe R, Dagg JH, Mackie RM. The staphylococcal scalded skin syndrome in two elderly immunocompromised patients. BMJ 1987; 295: 179–180PubMedCrossRefGoogle Scholar
  95. 95.
    Roeb E, Schonfelder T, Matern S, et al. Staphylococcal scalded skin syndrome in an immunocompromised adult. Eur J Clin Microbiol Infect Dis 1996; 15: 499–503PubMedCrossRefGoogle Scholar
  96. 96.
    Strumia R, Bedetti A, Cavazzini L. Staphylococcal scalded skin syndrome in corso di AIDS. G Ital Dermatol Venereol 1990; 125: 461–464PubMedGoogle Scholar
  97. 97.
    Farrell AM, Ross JS, Umasankar S, et al. Staphylococcal scalded skin syndrome in an HIV-1 seropositive man. Br J Dermatol 1996; 134: 962–965PubMedCrossRefGoogle Scholar
  98. 98.
    Hawley HB, Aronson MD. Scalded skin syndromes in adults. N Engl J Med 1972; 288: 130Google Scholar
  99. 99.
    Melish ME, Chen FS, Sprouse S, et al. Epidermolytic toxin in staphylococcal infection: toxin levels and host response. Zentralbl Bakteriol Mikrobiol Hyg Suppl 1981; 10: 287–298Google Scholar
  100. 100.
    Ridgway HB, Lowe NJ. Staphylococcal scalded skin syndrome in an adult with Hodgkin’s disease. Arch Dermatol 1979; 115: 589–590PubMedCrossRefGoogle Scholar
  101. 101.
    Melish ME, Glasgow LA. The staphylococcal scalded skin syndrome: the expanded clinical syndrome. J Paediatr 1971; 78: 958–967CrossRefGoogle Scholar
  102. 102.
    Rassmussen JE. Toxic epidermal necrolysis: a review of 75 cases in children. Arch Dermatol 1975; 111: 1135–1139CrossRefGoogle Scholar
  103. 103.
    Rudolph RI, Shwartz W, Leyden JJ. Treatment of staphylococcal toxic epidermal necrolysis. Arch Dermatol 1974; 110: 559–562PubMedCrossRefGoogle Scholar
  104. 104.
    Yokota S, Imagawa T, Katakura S, et al. Staphylococcal scalded skin syndrome caused by exfoliative toxin B-producing methicillin-resistant Staphylococcus aureus [letter]. Eur J Paediatr 1996; 155: 722Google Scholar
  105. 105.
    Mackenzie A, Johnson W, Heyes B, et al. A prolonged outbreak of exfoliative toxin A-producing Staphylococcus aureus in a newborn nursery. Diagn Microbiol Infect Dis 1995; 21: 69–75PubMedCrossRefGoogle Scholar

Copyright information

© Adis International Limited 2003

Authors and Affiliations

  1. 1.Department of DermatologyUniversity of Wales College of MedicineWalesUK

Personalised recommendations